ESEunA So

EunA So

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


EunA So has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Preliminary Study on the Development of a Biodegradable Functional Nasal Packing Material

    by Dong Hoon Lee, EunA So, Faizan E Mustafa, Jae-Ho Jeong, Bong-Kee Lee

    Introduction: Functional endoscopic sinus surgery is commonly performed to treat paranasal sinus diseases, often necessitating nasal packing to control bleeding and aid healing. However, current materials can cause discomfort or lack adequate antibacterial properties. This study aimed to develop a biodegradable, biocompatible nasal packing material by combining polyvinyl alcohol (PVA) and carbon dots (CDs), and to evaluate its antibacterial activity and tissue compatibility. Materials and Methods: Electrospun nanofiber membranes were fabricated using PVA and biomass-derived CDs. Antibacterial efficacy of nasal packing variants (PVA, PVA-chitosan [CS], PVA-CS-CDs-1 mL, and PVA-CS-CDs-2 mL) was assessed using the Kirby–Bauer disk diffusion method against Escherichia coli, Salmonella spp., and Staphylococcus aureus. The in vivo biocompatibility was evaluated via histological analysis following implantation into the nasal cavity of mice. Results: All materials demonstrated antibacterial activity, with PVA-CS-CDs-2 mL showing the largest inhibition zones. Histological examination revealed minimal epithelial damage and no inflammation, with PVA-CS-CDs-2 mL yielding the most favorable tissue response. Conclusion: The PVA-CS-CDs composite demonstrates potential as a biocompatible, antibacterial nasal packing material. Further studies are warranted to validate its long-term clinical utility.


  • Open Access

    Divergent Crosstalk Between Microglia and T Cells in Brain Cancers: Implications for Novel Therapeutic Strategies

    by Min-Hee Yi, Jinkyung Lee, Subin Moon, EunA So, Geonhyeok Bang, Kyung-Sub Moon, Kyung-Hwa Lee

    Background: Brain cancers represent a formidable oncological challenge characterized by their aggressive nature and resistance to conventional therapeutic interventions. The tumor microenvironment has emerged as a critical determinant of tumor progression and treatment efficacy. Within this complex ecosystem, microglia and macrophages play fundamental roles, forming intricate networks with peripheral immune cell populations, particularly T cells. The precise mechanisms underlying microglial interactions with T cells and their contributions to immunosuppression remain incompletely understood. Methods: This review comprehensively examines the complex cellular dialogue between microglia and T cells in two prominent brain malignancies: primary glioblastoma and secondary brain metastases. Results: Through a comprehensive review of the current scientific literature, we explore the nuanced mechanisms through which microglial-T cell interactions modulate tumor growth and immune responses. Conclusions: Our analysis seeks to unravel the cellular communication pathways that potentially underpin tumor progression, with the ultimate goal of illuminating novel therapeutic strategies for brain cancer intervention.


  • Open Access

    Constitutive Expression of a Cytotoxic Anticancer Protein in Tumor-Colonizing Bacteria

    by Phuong-Thu Mai, Daejin Lim, EunA So, Ha Young Kim, Taner Duysak, Thanh-Quang Tran, Miryoung Song, Jae-Ho Jeong, Hyon E. Choy

    Bacterial cancer therapy is a promising next-generation modality to treat cancer that often uses tumor-colonizing bacteria to deliver cytotoxic anticancer proteins. However, the expression of cytotoxic anticancer proteins in bacteria that accumulate in the nontumoral reticuloendothelial system (RES), mainly the liver and spleen, is considered detrimental. This study examined the fate of the Escherichia coli strain MG1655 and an attenuated strain of Salmonella enterica serovar Gallinarum (S. Gallinarum) with defective ppGpp synthesis after intravenous injection into tumor-bearing mice (~108 colony forming units/animal). Approximately 10% of the injected bacteria were detected initially in the RES, whereas approximately 0.01% were in tumor tissues. The bacteria in the tumor tissue proliferated vigorously to up to 109 colony forming units/g tissue, whereas those in the RES died off. RNA analysis revealed that tumor-associated E. coli activated rrnB operon genes encoding the rRNA building block of ribosome needed most during the exponential stage of growth, whereas those in the RES expressed substantially decreased levels of this gene and were cleared soon presumably by innate immune systems. Based on this finding, we engineered ΔppGpp S. Gallinarum to express constitutively a recombinant immunotoxin comprising TGFα and the Pseudomonas exotoxin A (PE38) using a constitutive exponential phase promoter, the ribosomal RNA promoter rrnB P1. The construct exerted anticancer effects on mice grafted with mouse colon (CT26) or breast (4T1) tumor cells without any notable adverse effects, suggesting that constitutive expression of cytotoxic anticancer protein from rrnB P1 occurred only in tumor tissue.